
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.510 | 2.510 | 0.000 |
Shares | 96.290 | 96.290 | 0.000 |
Preferred | 1.200 | 1.200 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.125 | 17.149 |
Price to Book | 4.810 | 3.706 |
Price to Sales | 5.641 | 5.005 |
Price to Cash Flow | 13.845 | 14.761 |
Dividend Yield | 0.478 | 0.525 |
5 Years Earnings Growth | 5.549 | 8.825 |
Number of long holdings: 63
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 5.96 | 109.00 | -2.76% | |
Vertex | US92532F1003 | 4.99 | 465.81 | -1.39% | |
Ascendis Pharma AS | US04351P1012 | 4.25 | 172.32 | -1.47% | |
BridgeBio Pharma | US10806X1028 | 3.61 | 47.13 | -1.18% | |
Amgen | US0311621009 | 3.61 | 292.81 | -1.42% | |
Alnylam | US02043Q1076 | 3.55 | 310.00 | -1.82% | |
Regeneron Pharma | US75886F1075 | 3.18 | 556.86 | -2.41% | |
AstraZeneca | GB0009895292 | 3.03 | 10,496.0 | -1.56% | |
Verona Pharma ADR | US9250501064 | 2.92 | 104.805 | +0.13% | |
Kalvista Pharma | US4834971032 | 2.90 | 14.75 | -3.09% |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review